NIH-funded research NIH-funded research

Complement in the heart’s microenvironment during renewal

Official title: COMPLEMENT IN THE CELLULAR MICROENVIRONMENT DURING CARDIAC RENEWAL

Funded at Temple Univ of the Commonwealth · NIH-11580896 · Data updated 2026-11-12

This grant explores how immune signals involving the Complement system help heart cells multiply to repair the heart after a heart attack, with the goal of helping patients recover better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTemple Univ of the Commonwealth
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 1, 2026
Project endJune 30, 2029
Funding year2026
Award (this year)$249,000
NIH project number4R00HL174827-04
Project IDNIH-11580896 on NIH RePORTER

Who could benefit from this research

Could help

Adults with ischemic heart disease or a history of myocardial infarction who may benefit from therapies that enhance heart muscle regeneration.

Less likely to help

People without ischemic heart disease or heart injury may not benefit from these findings.

What this research studies

The project looks at how heart cells called cardiomyocytes can re-enter the cell cycle and multiply after injury, and how cardiac fibroblasts and tissue-resident macrophages support this process through Complement signals. Researchers will study how C3 and C3AR1 activity in heart tissue influences cell proliferation and heart remodeling in models that resemble human disease. The aim is to uncover mechanisms that could lead to new therapies that promote heart repair rather than scar formation. This work could move toward strategies that reduce heart failure after myocardial infarction by boosting heart muscle regeneration.

Why it matters

Potential benefit: If successful, the work could lead to new treatments that help the heart regenerate after a heart attack and reduce the need for transplant.

How similar studies have gone: Previous studies show that certain neonatal and engineered heart conditions can trigger cardiomyocyte proliferation, suggesting this pathway could be translatable.

Where this research is happening

  • Temple Univ of the Commonwealth
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Li, Rich Gang — Temple Univ of the Commonwealth
  • Study coordinator: Li, Rich Gang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.